IP-Fälle und Artikel

SPCs: eligibility of a protein-bound drug

Supplementary protection certificates (SPCs) are available in Europe to extend the effective protection available to eligible products. To qualify, a product must be covered by a basic patent; must not be the subject of an earlier SPC; and must have been granted the first authorisation to place it on the market as a medicinal product (Article 3 of the SPC Regulation).